According to a recently published report, the global Blood Market is expected to grow by 9.27% CAGR during 2016-2022. The segmentation of global blood market is based on application, product and geography. The report on global blood market forecast 2016-2022 (by application, product and geography) provides detailed overview and predictive analysis of the market.
Full report is available onglobal blood market forecast 2016-2022 (by application, product and geography) report at http://www.briskinsights.com/report/blood-market
The increasing aging population and accumulative prevalence of peripheral vascular diseases is driving growth the global blood market.According to WHO, the world aging population has been expected to reach 2 billion by the end of 2050 which was 900 million in the year 2015. Now there are around 125 million people aged 80 years or more. In China, the population age above 65 years is expected to swell to 330 million by the end of 2050 which is 110 million at present. Whereas, India aged population is expected to cross 227 million by the end of 2050 from 60 million at present. This increase is nearly about 250% from today. By the end of 2050 almost 125 million people aged 80 years or more is expected to reach in China alone and 434 million people across the globe. Approximately 80% people live in low and middle income countries by the end of 2050.Overall it can be concluded that growing prevalence of aging population is and will be the major driver for the global blood market. Strict government regulations / compliance requirements, enactment of patient protection & affordable healthcare act, 2010 are the major restraint of the market whereas stringent government regulation is one of the major factor among all hindering the growth in the global market. The growth in the demand from emerging countries are creating huge opportunities for the global market. The rising concern for low cost medical treatment in such countries is increasing scope of blood market in the emerging countries. The growing number of surgeries in the developing countries is also escalating the growth in the blood market.
Scope of the report
1. GLOBAL BLOOD MARKET BY APPLICATION 2012-2022 ($ million)
1.4. INTRACRANIAL MONITORING IN STROKE AND BRAIN INJURY
1.5. PERIPHERAL VASCULAR DISEASES
1.6. TUMOR MONITORING AND ANGIOGENESIS
2. GLOBAL BLOOD MARKET BY PRODUCT 2012-2022 ($ million)
2.1. ELECTROMAGNETIC BLOOD FLOWMETERS
2.2. LASER DOPPLER BLOOD FLOWMETERS
2.3. ULTRASONIC DOPPLER BLOOD FLOWMETERS
3. GLOBAL BLOOD MARKET REGIONAL OUTLOOK 2012-2022($million)
3.1. NORTH AMERICA
3.3. ASIA PACIFIC
3.4. MIDDLE EAST & AFRICA
3.5. LATIN AMERICA
4. COMPANY PROFILES
4.1. ABBOTT LABORATORIES
4.2. ARJOHUNTLEIGH, INC.
4.3. BAXTER INTERNATIONAL INC.
4.4. BAYER AG
4.5. BIO-RAD LABORATORIES INC.
4.6. CSL BEHRING
4.7. DELTEX MEDICAL
4.8. GF HEALTH PRODUCTS
4.9. HAEMONETICS CORP.
4.10. HOLOGIC INC.
4.11. LFB GROUP
4.12. NOVO NORDISK A/S
4.13. OCTAPHARMA AG
4.14. PFIZER INC.
4.15. ROCHE HOLDING LTD.
Release ID: 2282